70
Views
2
CrossRef citations to date
0
Altmetric
Review

Smoking cessation and depression: current knowledge and future directions

, , , , , , , , , , , , & show all
Pages 97-107 | Received 03 Apr 2005, Accepted 04 Oct 2005, Published online: 12 Jul 2009

References

  • Murray C, Lopez A. The global burden of disease. World Health Organization, Geneva 1996
  • National Health Committee. Guidelines for smoking cessation. National Health Committee, WellingtonNew Zealand May 2002
  • Peto R, Lopez A, Boreham J, Thun M, Heath C. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339: 1268–1278
  • Wilhelm K, Mitchell P, Slade T, Brownhill S, Andrews G. Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Disord 2003; 75: 155–162
  • Kessler R, McGonagle K, Zhao S, Nelson C, Hughes M, Eshleman S, Wittchen H, Kendler K. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994; 51: 8–19
  • Covey L, Glassman A, Stetner F. Cigarette smoking and major depression. J Addict Dis 1998; 17: 35–46
  • Burgess E, Brown R, Kahler C, Niaura R, Abrams D, Goldstein M, Miller I. Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse?. Journal of Consulting & Clinical Psychology 2002; 70: 356–361
  • Andrews G, Hall W, Henderson S. Prevalence, comorbidity, disability and service utilisation: An overview of the Australian National Mental Health Survey. 2001, Submitted for publication
  • Zwar N, Richmond R, Borland R, Stillman S, Cunningham M, Litt J. Smoking cessation guidelines for Australian general practice: practice handbook. Commonwealth Dept of Health and Ageing. 2004
  • Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. The Cochrane Database of Systematic Reviews. 2004
  • Anda R, Williamson D, Escobedo L, Mast E, Giovino G, Remington P. Depression and the dynamics of smoking. A national perspective. Journal of the American Medical Association 1990; 264: 1541–1545
  • Glassman A, Covey L, Dalack G, Stetner F, Rivelli S, Fleiss J, Cooper T. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clinical Pharmacology & Therapeutics 1993; 54: 670–679
  • Malone K, Waternaux C, Haas G, Cooper T, Li S, Mann J. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. Am J Psychiatry 2003; 160: 773–779
  • Breslau N, Schultz L, Johnson E, Peterson E, Davis G. Smoking and the risk of suicidal behavior: a prospective study of a community sample. Arch Gen Psychiatry 2005; 62: 328–334
  • Angst J, Clayton P. Personality, smoking and suicide: a prospective study. J Affect Disord 1998; 51: 55–62
  • Glassman A, Covey L, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. The Lancet 2001; 357: 1929–1932
  • Breslau N, Kilbey M, Andreski P. DSM-III-R nicotine dependence in young adults: prevalence, correlates and associated psychiatric disorders. Addiction 1994; 89: 743–754
  • Breslau N. Psychiatric comorbidity of smoking and nicotine dependence. Behav Genet 1995; 25: 95–101
  • Breslau N, Johnson E, Hiripi E, Kessler R. Nicotine dependence in the United States: prevalence, trends, and smoking persistence. Archives of General Psychiatry 2001; 58: 810–816
  • Covey L, Glassman A, Stetner F. Depression and depressive symptoms in smoking cessation. Compr Psychiatry 1990; 31: 350–354
  • Hurt R, Sachs D, Glover E, Offord K, Johnston J, Khayallah M, Schroeder D, Glover P, Sullivan C, Croghan T, Sullivan P. A comparison of sustained release bupropion and placebo for smoking cessation. N Engl J Med 1998; 337: 1230–1231
  • Covey L, Glassman A, Stetner F. Major depression following smoking cessation. Am J Psychiatry 1997; 154: 263–265
  • Kendler K, Neale M, MacLean C, Heath A, Eaves L, Kessler R. Smoking and major depression: a causal analysis. Arch Gen Psychiatry 1993; 50: 36–43
  • Pomerleau C, Aubin H, Pomerleau O. Self-reported alcohol use patterns in a sample of male and female heavy smokers. J Addict Dis 1997; 16: 19–24
  • Tizabi Y, Overstreet D, Rezvani A, Louis V, Clark E, Janowsky D, Kling M. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology (Berl) 1999; 142: 193–199
  • Balfour D, Ridley D. The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?. Pharmacol Biochem Be 2000; 66: 79–85
  • Vazquez-Palacios G, Bonilla-Jaime H, Velazquez-Moctezuma J. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Progress in Neuro Psychopharmacology & Biological Psychiatry 2005; 29: 39–46
  • Fowler J, Logan J, Wang G, Volkow N. Monoamine oxidase and cigarette smoking. Neurotoxicology 2003; 24: 75–82
  • Mueser K, Drake R, Wallach M. Dual diagnosis: a review of etiological theories. Addict Behav 1998; 23: 717–734
  • Breslau N, Peterson E, Schultz L, Chilcoat H, Andreski P. Major depression and stages of smoking. A longitudinal investigation. Arch Gen Psychiatry 1998; 55: 161–166
  • Jorm A, Rodgers B, Jacomb P, Christensen H, Henderson S, Korten A. Smoking and mental health: results from a community survey. Med J Aust 1999; 170: 74–77
  • Kay-Lambkin F, Baker A, Lewin T. The ‘co-morbidity roundabout’: a framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems. Drug & Alcohol Review 2004; 23: 407–423
  • Schuckit M, Tipp J, Bergman M, Reich W, Hesselbrock V, Smith T. Comparison Psychiatry 1997; 154: 948–957
  • Hughes J. Treating smokers with current or past alcohol dependence. American Journal of Health Behavior 1996; 20: 286–290
  • Kandel D, Johnson J, Bird H, Canino G, Goodman S, Lahey B, Regier D, Schwab-Stone M. Psychiatric disorders associated with substance use among children and adolescents: findings from the Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study. J Abnorm Child Psychol 1997; 25: 121–132
  • Miller N, Gold M. Comorbid cigarette and alcohol addiction: epidemiology and treatment. J Addict Dis 1998; 17: 55–66
  • Rey J, Tennant C. Cannabis and mental health. BMJ 2002; 325: 1183–1184
  • Reilly D, Didcott P, Swift W, Hall W. Long-term cannabis use: characteristics of users in an Australian rural area. Addiction 1998; 93: 837–846
  • Patton G, Coffey C, Carlin J, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: cohort study. Br Med J 2002; 325: 1195–1198
  • Bovasso G. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001; 158: 2033–2037
  • Ford D, Vua H, Anthony J. Marijuana use and cessation of tobacco smoking in adults from a community sample. Drug Alcohol Depend 2002; 67: 243–248
  • Gourlay S, Forbes A, Marriner T, Pethica D, McNeil J. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ 1994; 309: 842–846
  • Smart R, Ogborne A. Drug use and drinking among students in 36 countries. Addict Behav 2000; 25: 455–460
  • Ramsay M, Spiller J. Drug misuse declared in 1996: latest results from the British Crime Survey. Home Office, London 1997
  • Gledhill-Hoyt J, Lee H, Strote J, Wechsler H. Increased use of marijuana and other illicit drugs at US colleges in the 1990s: results of three national surveys. Addiction 2000; 95: 1655–1667
  • Beckham J, Roodman A, Shipley R, Hertzberg M, Cunha G, Kudler H, Levin E, Rose J, Fairbank J. Smoking in Vietnam combat veterans with post-traumatic stress disorder. J Trauma Stress 1995; 8: 461–472
  • Amering M, Bankier B, Berger P, Griengl H, Windhaber J, Katschnig H. Panic disorder and cigarette smoking behavior. Compr Psychiatry 1999; 40: 35–38
  • Breslau N, Klein D. Smoking and panic attacks: an epidemiologic investigation. Arch Gen Psychiatry 1999; 56: 1141–1147
  • Pohl R, Yeragni V, Balon R. Smoking in patients with panic disorder. Psychiatry Res 1992; 43: 253–262
  • Sonntag H, Wittchen H, Hofler M, Kessler S, Stein M. Are social fears and DSM-IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults?. European Psychiatry 2000; 15: 67–74
  • Wilhelm K, Parker G, Dewhurst-Savellis J, Asghari A. Psychological predictors of single and recurrent major depressive episodes. J Affect Disord 1999; 54: 139–147
  • Karan L, J R. Addictive capacity of nicotine. American Psychiatric Press, Washington, DC 2000
  • Fiore M. A clinical practice guideline for treating tobacco use and dependence: a US Public Health Service report. Journal of American Medical Association 2000; 283: 3244–3254
  • Parker G. Beyond major depression. Psychol Med 2005; 35: 467–474
  • Hill J, Pickles A, Rollinson L, Davies R, Byatt M. Juvenile- versus adult-onset depression: multiple differences imply different pathways. Psychol Med 2004; 34: 1483–1493
  • Hickie I, Simons L, Naismith S, Simons J, McCallum J, Pearson K. Vascular risk to late-life depression: evidence from a longitudinal community study. Australian & New Zealand Journal of Psychiatry 2003; 37: 62–65
  • Killen J, Fortmann S, Schatzberg A, Hayward C, Varady A. Onset of major depression during treatment for nicotine dependence. Addict Behav 2003; 28: 461–470
  • Hall S, Munoz R, Reus V. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. Journal of Consulting & Clinical Psychology 1994; 62: 141–146
  • Brown R, Kahler C, Niaura R, Abrams D, Sales S, Ramsey S, Goldstein M, Burgess E, Miller I. Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting & Clinical Psychology 2001; 69: 471–480
  • Solberg L, Desai J, O'Connor P, Bishop D, Devlin H. Diabetic patients who smoke: are they different?. Annals of Family Medicine 2004; 2: 26–32
  • Centers for disease control and prevention. Cigarette smoking among adults. Morbidity and Mortality Weekly Report, United States 2004; 427–431
  • Australian Institute of Health and Welfare. 2001 National Drug Strategy Household Survey: Detailed Findings. AIHW (AIHW cat no. PHE.41). Canberra 2002
  • Husten K, Jackson C, Lee C. Cigarette smoking among adults. Morbidity and Mortality Weekly Report. 2004; 427–431
  • Australian Bureau of Statistics. 4701.0. Occasional paper: Smoking among Indigenous Australians. Canberra 1994
  • Coleman T. ABC of smoking cessation. Special groups of smokers. Br Med J 2004; 575–577
  • Woodruff S, Talavera G, Elder J. Evaluation of a culturally appropriate smoking cessation intervention for Latinos. Tob Control 2002; 11: 361–367
  • Munoz R, Marin B, Posner S, Perez-Stable E. Mood management mail intervention increases abstinence rates for Spanish-speaking Latino smokers. Am J Community Psychol 1997; 25: 325–343
  • Butler T, Belcher J, Richmond R, Wodak A, Wilhelm K. High smoking rates in NSW prisons: area of concern and opportunities, Drug Alcohol Rev Submitted
  • Abdullah A, Lam T, Chan S, Hedley A. Which smokers use the smoking cessation Quitline in Hong Kong, and how effective is the Quitline?. Tob Control 2004; 13: 415–421
  • Khlat M, Sermet C, Le Pape A. Increased prevalence of depression, smoking, heavy drinking and use of psycho-active drugs among unemployed men in France. Eur J Epidemiol 2004; 19: 445–451
  • Baker A, Ivers R G, Bowman J, et al. Where there's smoke, there's fire: high prevalence of smoking among some sub-populations and recommendations for intervention. Drug Alcohol Rev 2006; 25: 85–96
  • Haaga D, Thorndike F, Friedman-Wheeler D, Pearlman M, Wernicke R. Cognitive coping skills and depression vulnerability among cigarette smokers. Addict Behav 2004; 29: 1109–1122
  • Ginsberg J, Klesges R, Johnson K, Eck L, Meyers A, Winders S. The relationship between a history of depression and adherence to a multicomponent smoking-cessation program. Addict Behav 1997; 22: 783–787
  • Hall S, Humfleet G, Reus V, Muñoz R, Hartz D, Maude-Griffin R. Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry 2002; 59: 930–936
  • Emmons K, Rollnick S. Motivational interviewing in health care settings. Opportunities and limitations. Am J Prev Med 2001; 20: 68–74
  • Miller W, Rollnick S. Motivational interviewing: preparing people for change. 2002
  • Richmond R, Harris K. Becoming a non-smoker: giving up for good. 1999
  • Hall S, Munoz R, Reus V, Sees K, Duncan C, Humfleet G, Hartz D. Mood placebo-controlled study. Journal of Consulting & Clinical Psychology 1996; 64: 1003–1009
  • Fergusson D, Goodwin R, Horwood L. Major depression and cigarette smoking: results of a 21-year longitudinal study. Psychol Med 2003; 33: 1357–1367
  • Stead L, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews. 2002
  • Swan G, Jack L, Curry S, Chorost M, Javitz H, McAfee T, Dacey S. Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome. Nicotine & Tobacco Research 2003; 5: 911–921
  • Hass A, Munoz R, Humfleet G, Reus V, Hall S. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. Journal of Consulting & Clinical Psychology 2004; 72: 563–570
  • Hall S, Reus V, Munoz R, Sees K, Humfleet G, Hartz D, Frederick S, Triffleman E. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998; 55: 683–690
  • Kendall P, Kortlander E, Chansky T, Brady E. Comorbidity of anxiety and depression in youth: treatment implications. Journal of Consulting & Clinical Psychology 1992; 60: 869–880
  • Charney D, Paraherakis A, Negrete J, Gill K. The impact of depression on the outcome of addictions treatment. J Subst Abuse Treat 1998; 15: 123–130
  • Ries R. Clinical treatment matching models for dually diagnosed patients. Psychiatr Clin North Am 1993; 16: 167–175
  • Drake R, Mercer-McFadden C, Mueser K, McHugo G, Bond G. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 1998; 24: 589–608
  • Jain A. Treating nicotine addiction. Br Med J 2003; 327: 1394–1395
  • Wilhelm K, Niven H, Mitchell P, Malhi G, Wedgwood L, Austin M -P, Kotze B, Parker G. Actions taken to cope with depression in patients seeking specialist care. Australian and New Zealand of psychiatry in press
  • Jorm A, Griffiths K, Christensen H, Parslow R, Rogers B. Actions taken to cope with depression at different levels of severity: a community survey. Psychol Med 2004; 34: 293–299
  • American Psychiatric Association. Practice guidelines for the treatment of patients with nicotine dependence. Am J Psychiatry 1996; s1–s31
  • American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. Am J Psychiatry 2000; 159: 1–45
  • Sorensen G, Goldberg R, Ockene J, Klar J, Tannenbaum T, Lemeshow S. Heavy smoking among a sample of employed women. Am J Prev Med 1992; 8: 207–214
  • Van de Vliet P, Vanden Auweele Y, Knapen J, Rzewnicki R, Onghena P, Van Coppenolle H. The effect of fitness training on clinically depressed patients: An intra-individual approach. Psychology of Sport & Exercise 2004; 5: 153–167
  • Mutrie N. Healthy body, healthy mind?. Psychologist 2002; 15: 412–413
  • Blumenthal J, Babyak M, Moore K, Craighead W, Herman S, Khatri P, Waugh R, Napolitano M, Forman L, Appelbaum M, Doraiswamy P, Krishnan K. Effects of exercise training on older patients with major depression. Arch Intern Med 1999; 159: 2349–2356
  • Atlantis E, Chow C, Kirby A, Singh M. An effective exercise-based intervention for improving mental health and quality of life measures: a randomized controlled trial. Prev Med 2004; 39: 424–434
  • Craft L, Landers D. The effect of exercise on clinical depression and depression resulting from mental illness: A meta-analysis. Journal of Sport & Exercise Psychology 1998; 20: 339–357
  • Ussher M, West R, Taylor A, McEwen A. Exercise interventions for smoking cessation. 2005
  • Choy D, Lutzker L, Meltzer L. Effective treatment for smoking cessation. Am J Med 1983; 75: 1033–1036
  • He D, Medbo J, Hostmark A. Effect of acupuncture on smoking cessation or reduction: an 8-month and 5-year follow-up study. Prev Med 2001; 33: 364–372
  • Pickworth W, Fant R, Butschky M, Goffman A, Henningfield J. Evaluation of cranial electrostimulation therapy on short-term smoking cessation. [see comment]. Biol Psychiatry 1997; 42: 116–121
  • Spiegel D, Frischholz E, Fleiss J, Spiegel H. Predictors of smoking abstinence following a single-session restructuring intervention with self-hypnosis. Am J Psychiatry 1993; 150: 1090–1097
  • White A, Rampes H, Ernst E. Acupuncture for smoking cessation. The Cochrane Database of Systematic Reviews. 2002
  • Abbot N, Stead L, White A, Barnes J, Ernst E. Hypnotherapy for smoking cessation. Cochrane Database of Systematic Reviews. 2000; 2
  • Dierker L, Avenevoli S, Stolar M, Merikangas K. Smoking and depression: an examination of mechanisms of comorbidity. Am J Psychiatry 2002; 159: 947–953
  • Kinnunen T, Doherty K, Militello F, Garvey A. Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement. Journal of Consulting & Clinical Psychology 1996; 64: 791–798
  • Blondal T, Gudmundsson L, Olafsdottir I, Gustavsson G, Westin A. Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. [see comment][erratum appears in BMJ 1999 Mar 20;318(7186):764]. BMJ 1999; 318: 285–288
  • George T, O'Malley S. Current pharmacological treatments for nicotine dependence. Trends Pharmacol Sci 2004; 25: 42–48
  • Cummings K, Hyland A. Impact of nicotine replacement therapy on smoking behavior. Annu Rev Public Health 2005; 26: 583–599
  • Strasser A, Kaufmann V, Jepson C, Perkins K, Pickworth W, Wileyto E, Rukstalis M, Audrain-McGovern J, Lerman C. Effects of different nicotine replacement therapies on postcessation psychological responses. Addict Behav 2005; 30: 9–17
  • Salin-Pascual R, Rosas M, Jimenez-Genchi A, Rivera-Meza B, Delgado-Parra V. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 1996; 57: 387–389
  • Medioni J, Berlin I, Mallet A. Increased risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approach. Addiction 2005; 100: 247–254
  • Foulds J, Steinberg M, Williams J, Ziedonis D. Developments in phamacotherapy for tobacco dependence: past, present and future. Drug Alcohol Rev 2006; 25: 59–71
  • Hughes J, Stead L, Lancaster T. Antidepressants for smoking cessation. 2004
  • Wiley J, Lavecchia K, Martin B, Damaj M. Nicotine-like discriminative stimulus effects of bupropion in rats. Experimental & Clinical Psychopharmacology 2002; 10: 129–135
  • Richmond R, Zwar N. Review of bupropion for smoking cessation. Drug Alcohol Rev 2003; 22: 61–63
  • Jorenby D, Scott J, Nides M, Rennard S, Johnston J, Hughes A, Smith S, Muamoto M, Daughton D, Doan K, Fiore M, Baker T. A controlled trial of sustained release bupropian, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685–691
  • Prochazka A, Kick S, Steinbrunn C, Miyoshi T, Fryer G. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation. Arch Intern Med 2004; 164: 2229–2233
  • Borrelli B, Niaura R, Keuthen N, Goldstein M, DePue J, Murphy C, Abrams D. Development of major depressive disorder during smoking-cessation treatment. J Clin Psychiatry 1996; 57: 534–538
  • Dalack G, Glassman A, Rivelle S, Covey L, Stetner F. Mood, major depression, and fluoxetine response in cigarette smokers. Am J Psychiatry 1995; 152: 398–403
  • Berlin I, Said S, Spreux-Varoquaux O, Olivares R, Launay J, Puech A. Monoamine oxidase A and B activities in heavy smokers. Biol Psychiatry 1995; 38: 756–761
  • Hays J, Hurt R, Rigotti N, Niaura R, Gonzales D, Durcan M, Sachs D, Wolter T, Buist A, Johnston J, White J. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Ann Intern Med 2001; 135: 423–433
  • Baker A, Dawe S. Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment. Australian Psychologist 2005; 40: 88–95
  • Scogin F, Hanson A, Welsh D. Self-administered treatment in stepped-care models of depression treatment. J Clin Psychol 2003; 59: 341–349
  • Smith S, Jorenby D, Fiore M, Anderson J, Mielke M, Beach K, Piasecki T, Baker T. Strike while the iron is hot: Can stepped-care treatments resurrect relapsing smokers?. Journal of Consulting & Clinical Psychology 2001; 69: 429–439
  • Coleman T, Cheater F, Murphy E. Qualitative study investigating the process of giving anti-smoking advice in general practice. Patient Education & Counseling 2004; 52: 159–163
  • Myrick H, Brady K. Current review of the comorbidity of affective, anxiety, and substance use disorders. Current Opinion in Psychiatry May, 2003; 16: 261–270
  • Simon J, Duncan C, Carmody T, Hudes E. Bupropion for smoking cessation: a randomized trial. Arch Intern Med 2004; 164: 1797–1803
  • Smith S, Jorenby D, Leischow S, Nides M, Rennard S, Johnston J. Jamerson and those with a history of depression. Nicotine & Tobacco Research 2003; 5: 99–109
  • Wilhelm K, Arnold K, Niven H, Richmond R. Grey lungs and blue moods: smoking cessation in the context of lifetime depression history. Australian & New Zealand Journal of Psychiatry 2004; 38: 896–905
  • Unrod M, Cook T, Myers M, Brown S. Smoking cessation efforts among substance abusers with and without psychiatric comorbidity. Addict Behav 2004; 29: 1009–1013
  • Bjartveit K, Tverdal A. Health consequences of smoking 1-4 cigarettes per day. Tob Control 2005; 14: 315–320
  • Falba T, Jofre-Bonet M, Busch S, Duchovny N, Sindelar J. Reduction of quantity smoked predicts future cessation among older smokers. Addiction 2004; 99: 93–102
  • Hughes J R, Hatsukami D K, Mitchell J E, Dahlgren L A. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986; 143: 993–997
  • Goff D, Henderson D, Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry 1992; 149: 1189–1194

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.